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Abstract
The International Study of Asthma and Allergies in Childhood (ISAAC) Phase One showed large worldwide varia-
tions in the prevalence of symptoms of asthma, rhinoconjunctivitis and eczema, up to 10 to 20 fold between
countries. Ecological analyses were undertaken with ISAAC Phase One data to explore factors that may have con-
tributed to these variations, and are summarised and reviewed here.
In ISAAC Phase One the prevalence of symptoms in the past 12 months of asthma, rhinoconjunctivitis and eczema
were estimated from studies in 463,801 children aged 13 - 14 years in 155 centres in 56 countries, and in 257,800
children aged 6-7 years in 91 centres in 38 countries. Ecological analyses were undertaken between symptom pre-
valence and the following: Gross National Product per capita (GNP), food intake, immunisation rates, tuberculosis
notifications, climatic factors, tobacco consumption, pollen, antibiotic sales, paracetamol sales, and outdoor air
pollution.
Symptom prevalence of all three conditions was positively associated with GNP, trans fatty acids, paracetamol, and
women smoking, and inversely associated with food of plant origin, pollen, immunisations, tuberculosis notifica-
tions, air pollution, and men smoking. The magnitude of these associations was small, but consistent in direction
between conditions. There were mixed associations of climate and antibiotic sales with symptom prevalence.
The potential causality of these associations warrant further investigation. Factors which prevent the development
of these conditions, or where there is an absence of a positive correlation at a population level may be as impor-
tant from the policy viewpoint as a focus on the positive risk factors. Interventions based on small associations may
have the potential for a large public health benefit.
What was ISAAC Phase One?
The International Study of Asthma and Allergies in
Childhood (ISAAC) Phase One studied symptom preva-
lence and severity of asthma, rhinoconjunctivitis and
eczema between populations around the world to eluci-
date factors influencing these conditions. This multi-
centre cross-sectional study was undertaken between
1992 and 1997 using standardised methodology with
subjects being school children from schools which were
randomly sampled within centres [1]. Two age groups
of children (13-14 and 6-7 years) were studied, with a
target sample size of 3,000 children per age group per
centre. Simple written questionnaires were self-com-
pleted by the 13-14 year old participants, and by the
parents of the 6-7 year old participants. These question-
naires were translated from English into a local language
where appropriate. An optional video asthma question-
naire was delivered to the 13-14 year age group, with
verbal instructions in the local language. The participa-
tion rates averaged 92% for the 13-14 year age group
and 89% for the 6-7 year age group. The findings of
large variations in the symptom prevalence of asthma,
rhinoconjunctivitis and eczema, up to 10 to 20 fold
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between countries, around the world [2-5] suggested
that environmental rather than genetic factors may be
most influential.
One of the scientific driving forces behind the ISAAC
collaboration was the suspicion that causes of asthma in
high prevalence countries might be so widespread that it
would be difficult if not impossible to detect them by
comparisons between individuals within those countries.
The very large number of participating centres (156)
and countries (56) in ISAAC Phase One was an ideal
opportunity to look at potential causes between popula-
tions. Ecological analyses are an appropriate method to
do this to generate hypotheses which may explain these
variations. Thus ecological analyses were undertaken
with ISAAC Phase One symptom prevalence estimates,
using a wide range of data sources at a population level,
on a variety of environmental topics [6-17]. The findings
for the potentially protective or risk factors examined
which are relevant for asthma, rhinoconjunctivitis and
eczema are reviewed and interpreted in this paper.
What ecological analyses were undertaken?
Ecological analyses were undertaken with ISAAC Phase
One symptom prevalence data for asthma, rhinocon-
junctivitis and eczema with environmental data from
existing sources. In some cases environmental data was
unavailable for all centres or countries. The effect of
country level economic development was examined
using the 1993 Gross National Product per capita
(GNP) as reported by the World Bank for all 156 cen-
tres in 56 countries involved in Phase One [14]. Dietary
factors were assessed using Food and Agriculture Orga-
nization FAOSTAT food balance sheets for 1995 in 53
countries. Food produced and imported, less food
exported gave the country supply of food from which
was estimated the per capita supply of food [9]. Associa-
tions with consumption of trans fatty acids were
assessed in 55 centres in 10 European countries using
data from 1999 [17]. Immunisation rates at a national
level were obtained from the World Health Organiza-
tion (WHO) for 56 countries, and immunisation rates at
a centre level were obtained through ISAAC Principal
Investigators in 92 ISAAC centres for vaccines against
diphtheria, tetanus, pertussis, BCG and measles [7]. The
years selected for the immunisation data (1982 for the
13-14 year age group and 1989 for the 6-7 year age
group) approximately corresponded to the year of birth
of the participants. Tuberculosis (TB) exposure was
assessed in two ways - firstly using notification rates
from WHO data for 1980-1982 in 23 countries for the
13-14 year age group at the time when the older age
group would have been infants [15]; secondly from
WHO TB estimated incidence for the 6-7 year age
group in 38 countries and 55 countries for the 13-14
year age group in 1995, the mean year of the data col-
lection for the older age group [13]. Climatic factors
were assessed using data from the World Weather
Guide and derived variables for 146 ISAAC centres [16]
and a subset of 57 centres in 12 countries in Western
Europe. Tobacco exposure was assessed using WHO
data for tobacco consumption per capita 1990-1992, and
tobacco smoking prevalence in women and tobacco
smoking in men in 155 centres from 56 countries [11].
Pollen exposure was assessed using data for pollen
counts, and duration and severity of pollen seasons in
28 centres in 11 countries for 1995 [8]. Associations
with antibiotic use was assessed using data for antibiotic
sales for 28 countries from International Medical Statis-
tics, Health Global Services, United Kingdom 1995 [10].
Air pollution was assessed for 105 centres in 51 coun-
tries using the World Bank Global Model on Ambient
Particulates for 1999 which estimated annual concentra-
tions for all cities with populations of more than
100,000 [6]. Paracetamol exposure was assessed using
data for paracetamol sales per capita in 106 centres [12].
Each analysis is described in detail elsewhere [6-17].
For all analyses mixed model regression analyses were
carried out to incorporate the country and centre struc-
ture of the data sets, except trans fatty acids where lin-
ear regressions were used. ISAAC data was at the centre
level, but most environmental data sets represented
whole countries, therefore mostly country level was used
in the analyses as specified in the source articles. Excep-
tions were air pollution and climate which could be ana-
lysed at centre (city) level. A variety of measures of
association were used for the analyses such as Spearman
rank correlation coefficient, and the statistical signifi-
cance level used was p < 0.05. Non-statistically signifi-
cant trends were noted where they were consistent with
significant findings. The analyses did not examine com-
binations and interactions of the variables.
As GNP was found to have a weak positive association
with symptom prevalence [14], the analyses of other
environmental factors were repeated with GNP in the
model. The findings presented in this paper pertain to
analyses adjusted for GNP, but not adjusted for any
other variables. Although the published papers analysed
most of the ISAAC questions, this paper reviews only
the analyses of symptoms in the past 12 months of
asthma, rhinoconjunctivitis and eczema.
What were the key findings?
The ecological analyses in both age groups demon-
strated mostly weak relationships of small magnitude
between environmental variables and current symptoms
of asthma, rhinoconjunctivitis and eczema, or no asso-
ciation at all. The results are summarised in Table 1,
Table 2 and Table 3. Where associations were found
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these were generally in the same direction for all three
conditions, but were statistically significant for only
some associations [6-9,11,12,14,17]. A weak positive
association was found between asthma and eczema
symptoms and GNP. Weak positive associations were
found between symptom prevalence and tobacco con-
sumption, smoking by women, trans fatty acids and
paracetamol. Weak inverse associations were found for
plant-based foods, immunisation for DTP and measles,
tuberculosis incidence pollen exposure, smoking by
men. A mixed pattern of associations were found for
antibiotic sales and climate. For air pollution, in those
countries with more than one centre, the association
was weakly positive, in contrast to the weakly negative
association at country level.
What do these findings mean? - methodological
issues
This is the first large worldwide analysis of protective
and risk factors related to asthma, rhinoconjunctivitis
and eczema in children between populations. Standar-
dised methodology was used to estimate the 12 month
period prevalence of symptoms of the three conditions.
The recall of 12 month symptoms is a more accurate
Table 1 Symptoms of wheeze in the past 12 months - summary of ecological analyses*.
Ecological Issue Specific Factor 13-14 Year Age Group 6-7 Year Age Group
Written Questionnaire Video Questionnaire Written Questionnaire
Direction of
effect
P
Value
Direction of
effect
P
Value
Direction of
effect
P
value
Economic
development
GNP + 0.007 + 0.08 + 0.84
Diet Calories from cereals and rice % - 0.0005 - 0.07 - 0.021
Protein from cereals and nuts % - 0.002 - 0.015 - 0.062
Starch g/day - 0.008 - 0.01 - 0.036
Vegetables g/d - 0.041 - 0.205 - 0.262
Vegetable Vitamin A μ/d - 0.04 - 0.159 - 0.235
Trans fatty acids + <
0.0001
+ < 0.05
Immunisation Local immunisation rates for DTP# - 0.047 - > 0.05
Local immunisation rates for measles - > 0.05 - > 0.05
TB exposure TB notification rates - 0.344 - 0.018
Estimated TB incidence rates - 0.262 - 0.263 - <
0.0001
Outdoor climate Altitude - > 0.05 + > 0.05 - > 0.05
Annual variation in mean temperature - > 0.05 - > 0.05 - > 0.05
Lowest monthly mean temperature + > 0.05 0 > 0.05 + > 0.05
Annual variation in mean relative humidity - > 0.05 + > 0.05 - > 0.05
Lowest monthly mean relative humidity 0 > 0.05 - > 0.05 0 < 0.05
Mean relative humidity of ≥ 1 month <
50%humidity
+ > 0.05 + > 0.05 + > 0.05
Indoor climate Mean annual relative humidity 0 > 0.05 - > 0.05 - > 0.05
Lowest monthly mean relative humidity + > 0.05 0 > 0.05 0 > 0.05
Tobacco smoking Tobacco consumption, ≥ 15 yrs 0 0.92 + 0.53 + 0.46
Tobacco smoking, women + 0.06 + 0.72 + 0.32
Tobacco smoking, men - 0.001 - 0.004 - 0.06
Pollen Total grass pollen count - 0.67
Days with high pollen counts - 0.39
Antibiotic usage Antibiotic sales per capita - 0.21 + 0.01
Air pollution PM10 - 0.03 - 0.06
Paracetamol Per capita paracetamol sales + <
0.0005
+ 0.001
*standardized for GNP. Where p values are recorded as > 0.05 the non significant p values were not provided in the source publication. #DTP = Diphtheria and
tetanus toxoids and pertussis.
Blank space = data not collected. + = positive association. - = inverse association. 0 = no association.
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assessment of disease than diagnostic labelling which is
subject to recall bias and different diagnostic fashions
especially in such diverse parts of the world.
As country level environmental data was used most
commonly (because centre-level data was unavailable)
associations at the country level may have introduced
complex biases when analysed against centre-level
symptoms, and thus some caution is required in the
interpretation of the results. This is illustrated by the
contrasting results for air pollution.
The global coverage of ISAAC is advantageous in
terms of scope and size for ecological analyses, making
them potentially more robust than smaller less represen-
tative studies. Multiple languages were used which raises
the possibility of population level confounding. However
the variations in prevalence of asthma from the written
questionnaire were similar in their global distribution to
the prevalence from the video questionnaire [2].
Furthermore recent analysis suggests that translations of
the written questionnaire are reasonably accurate [18],
and several of the papers have reported consistent find-
ings for within-region or within-language comparisons
which is reassuring. The most robust comparisons, from
this viewpoint, are those based on comparisons between
centre-level symptom prevalence values and centre level
environmental exposures as occurred for the air pollu-
tion [6] and immunisation [7] analyses. Further, the
results of parental responses for the younger children
were similar to those of the responses from the older
children.
The ecological approach attempted to find factors
which explained the large international variation, but we
are unable to tell which factors are relevant to asthma
causation. For example if everyone smoked then smok-
ing wouldn’t explain any of the international variation,
even if it was an important risk factor for asthma
(although if there was a strong dose response an effect
might be found). It is not appropriate to compare the
Table 2 Symptoms of rhinoconjunctivitis in the past 12 months - summary of ecological analyses*.
Ecological Issue Specific Factor 13-14 Year Age Group 6-7 Year Age Group
Direction of effect P Value Direction of effect P Value
Economic development GNP + 0.12 0.06 0.32
Diet Calories from cereals and rice % - 0.007 - 0.083
Protein from cereals and nuts % - 0.039 - 0.111
Starch g/d - 0.266 - 0.069
Vegetables g/d - 0.083 - 0.453
Vegetable Vitamin A μ/d - 0.085 - 0.479
Trans fatty acids + < 0.0001
Immunisation Local immunisation rates for DTP# + 0.002 - > 0.05
Local immunisation rates for measles - 0.015 - > 0.05
TB exposure TB notification rates, WHO - 0.015
Outdoor climate Altitude - > 0.05 - > 0.05
Annual variation in mean temperature - > 0.05 - > 0.05
Lowest monthly mean temperature + > 0.05 + > 0.05
Annual variation in mean relative humidity + > 0.05 - > 0.05
Lowest monthly mean relative humidity - > 0.05 - > 0.05
Mean relative humidity of ≥ 1 month < 50%humidity + > 0.05 + > 0.05
Indoor climate Mean annual relative humidity + > 0.05 + > 0.05
Lowest monthly mean relative humidity + > 0.05 + > 0.05
Tobacco smoking Tobacco consumption, ≥ 15 yrs - 0.86 + 0.52
Tobacco smoking, women - 0.68 + 0.76
Tobacco smoking, men - < 0.001 - 0.06
Pollen Total grass pollen count - 0.07
Days with high pollen counts - 0.14
Antibiotic usage Antibiotic sales per capita - 0.76
Air pollution PM10 - 0.49 - 0.06
Paracetamol Per capita paracetamol sales + < 0.0005 + 0.002
*standardized for GNP. Where p values are recorded as > 0.05 the non significant p values were not provided in the source publication. #DTP = Diphtheria and
tetanus toxoids and pertussis.
Blank space = data not collected. + = positive association. - = inverse association.
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size of the correlation coefficients, as the methods for
calculating these distort the effects, so that the magni-
tude of effect cannot be interpreted from them [19].
Notwithstanding these caveats, there are plausible
mechanisms for each association (discussed below), sug-
gesting that various factors associated with human
development may be affecting variations in symptom
prevalence between populations.
Explaining patterns of diseases across the world one
variable at a time may be fraught with difficulties, as dif-
ferent factors are likely to be more important in differ-
ent regions of the world. For example, climate may be
important in countries where there is variation in tem-
perature and humidity, and TB exposure will be of
potential importance where TB occurs, and not where it
doesn’t occur. It is also likely that these diseases are
multi component diseases, i.e. 3 or more factors need to
be present before disease may become manifest, but that
level of analysis has not been undertaken.
Economic factors
The associations observed suggest that economic devel-
opment of a country may bring with it changes influen-
cing asthma, rhinoconjunctivitis and eczema [14].
Further supportive evidence of this association was
found recently in ISAAC Phase Three where data from
98 countries showed that the prevalence of asthma
symptoms showed a positive relationship with Gross
National Income (GNI), although the prevalence of
severe symptoms correlated inversely with GNI [20].
However caution should be used in interpreting the
findings because of the great inequalities in income dis-
tribution within almost all countries in developing
regions of the world. GNP represents the total economic
activity of the country, reflecting mean wealth rather
Table 3 Symptoms of eczema in the past 12 months - summary of ecological analyses*.
Ecological Issue Specific Factor 13-14 Year Age Group 6-7 Year Age Group
Direction of effect P Value Direction of effect P Value
Economic development GNP + 0.05 + 0.02
Diet Calories from cereals and rice % - 0.246 - 0.767
Protein from cereals and nuts % - 0.028 - 0.07
Starch g/d - 0.560 - 0.058
Vegetables g/d - 0.001 - 0.157
Vegetable Vitamin A μ/d - 0.001 - 0.153
Trans fatty acids + < 0.0001
Immunisation Local immunisation rates for DTP# - 0.048 - > 0.05
Local immunisation rates for measles - 0.036 - > 0.05
TB exposure TB notification rates, WHO + 0.544
Outdoor climate Latitude 0 > 0.05 + > 0.05
Altitude + > 0.05 + > 0.05
Mean annual temperature - > 0.05 - > 0.05
Annual variation in mean temperature + < 0.05 + > 0.05
Lowest monthly mean temperature - > 0.05 - < 0.05
Annual variation in mean relative humidity - > 0.05 - > 0.05
Lowest monthly mean relative humidity - > 0.05 - > 0.05
Indoor climate Mean annual relative humidity - > 0.05 - < 0.05
Lowest monthly mean relative humidity 0 > 0.05 - > 0.05
Tobacco smoking Tobacco consumption, ≥ 15 yrs + 0.35 + 0.87
Tobacco smoking, women + 0.42 + 0.17
Tobacco smoking, men - 0.007 - 0.67
Pollen Total grass pollen count - 0.15
Days with high pollen counts - 0.32
Antibiotic usage Antibiotic sales per capita - 0.46
Air pollution PM10 - 0.07 - 0.10
Paracetamol Per capita paracetamol sales + < 0.0005 + 0.001
*standardized for GNP. Where p values are recorded as > 0.05 the non significant p values were not provided in the source publication. #DTP = Diphtheria and
tetanus toxoids and pertussis.
Blank space = data not collected. + = positive association. - = inverse association. 0 = no association.
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than median wealth. Thus countries with a highly
skewed income distribution due to concentration of
wealth in the hands of a small fraction of the population
may have a relatively high per capita GNP while the
majority of citizens have a relatively low level of income
[21]. A further consideration is that GNP does not mea-
sure factors that affect quality of life, such as the quality
of the environment.
Diet
Dietary patterns have changed rapidly with modernisation
or westernisation, and the associated move away from
plant-based foods and addition of man-made fats might
affect symptom prevalence. No associations were found
for meat, and milk, but showed a pattern of inverse asso-
ciation between plant-based food and symptoms of the
three conditions [9]. A protective effect of plant-based
food might be mediated through effects on intestinal
microflora which are necessary for maturation of Th1
immunity [22]. A further mechanism may be mediated
through antioxidant content. This is corroborated by the
positive association found between the prevalence of
symptoms of asthma, and paracetamol sales [12,23], and
more recent work showing associations between symp-
toms of all three conditions and paracetamol use [23]. The
analysis in European countries of trans fatty acids found a
positive association, suggesting that man-made fats may
be a factor in the prevalence of the three conditions [17].
Tobacco
The picture which emerged for tobacco was mixed with
no association observed with country tobacco consump-
tion [11]. However there was generally a positive rela-
tionship between women smoking and the three
conditions, yet an inverse association between men
smoking and the three conditions. This analysis indi-
cates that the well established individual level associa-
tion between parental cigarette smoking and asthma
does not account for the international differences in
asthma prevalence.
Tuberculosis
The inverse association found between asthma symptom
prevalence and estimated TB incidence [13] and actual
TB notifications rates [15] supports other evidence that
exposure to Mycobacterium tuberculosis may reduce the
risk of developing asthma. This may occur through
induction of Th1 type immune responses. The implica-
tions of this relationship in the changing world of TB
disease (the increase in AIDS and the concomitant
increase in TB cases in Africa and the decrease of TB in
other regions such as Latin America) need further study.
Immunisation
Two levels of immunisation analyses were undertaken:
country level, and centre level. The country level ana-
lyses showed no associations [7]. The more powerful
centre-level analyses showed small inverse relationships
between DTP and measles in the older age group only,
with no associations with BCG. In view of earlier reports
that immunisation might be a risk factor for asthma,
this mainly null result is reassuring for population
immunisation programmes, given their importance for
child health.
Antibiotics
The relationships between symptom prevalence and
antibiotic exposure was not clear cut. A mixture of
weak inverse and positive effects were found between
symptom prevalences and total antibiotic sales and
broad spectrum antibiotic sales [10]. This analysis sug-
gested that even if there was a potential causal associa-
tion of antibiotic use with asthma risk, it did not appear
to explain the world wide differences between countries.
The potential involvement, if any, of antibiotics may be
in the alteration of induction of immunity rather than
the exposure per se, and involve a combination of the
effects of infection and microbial exposure too.
Pollen
Exposure to allergenic pollen was assessed by exposures
around the dates of early life [8] and did not appear to
increase the risk of acquiring symptoms of respiratory
allergy, and may even give some protection. Other studies
have found that the symptom prevalence of hay fever and
asthma tends to be lower in rural than in urban areas, and
lowest among people living on farms [24-28], but this has
not been consistently found outside Europe and USA, and
was not studied in our analyses. The degree of consistency
in the inverse associations suggests the possibility of a pro-
tective effect of pollen on allergy.
Air pollution
A weak inverse relationship was demonstrated between
city-level particulate air pollution (PM10) and symptoms
of the three conditions, even after controlling for GNP
which has a strong inverse association with air pollution
[6]. Meta-analyses of data from countries with multiple
centres found by contrast a consistent pattern of weak
positive associations. These generally weak associations
were in line with existing ecological evidence on the
association between particulate air pollution and asthma.
This finding is not incompatible with the extensive evi-
dence from individual level studies that air pollution
may aggravate existing asthma, since this may not have
an important effect on prevalence. Short-term fluctua-
tions in pollutant levels may have different effects from
chronically high concentrations. Neither does it exclude
a causal role for roadside exposure for which there is
limited evidence. Higher self-reported exposure to truck
traffic obtained as part of ISAAC Phase Three was asso-
ciated with higher symptom prevalences [29].
Climate
As climate affects whole populations, ecological studies
are ideally suited to examine the relationship between
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prevalence of diseases and climatic conditions between
populations. In the worldwide analyses few significant
associations were seen [16]. However, in ISAAC studies
in two large continents with quite marked climate dif-
ferences - Latin America [30] and Africa [31] - no rela-
tionship was observed for asthma symptoms prevalence
with respect to latitude, altitude, humid/dry climate or
other geographical aspects, suggesting that meteorologi-
cal and geographic factors, individually, would not be
able to explain the wide variability in the prevalence of
asthma, rhinitis and eczema in the world. As the world
becomes more affected by climate change there may be
some regions such as Western Europe where prevalence
of disease is affected by potentially modifiable factors
including humidity and temperature [16], but at a global
level our ecological analyses showed little effect.
Is the ecological approach sound?
The central ISAAC approach has been to study symp-
toms of disease between populations, which has natu-
rally led to ecological analyses between symptom
prevalences and potential environmental exposures. As
Rose states, “the primary determinants of disease are
mainly economic and social, and therefore its remedies
must also be economic and social” [32], and this has
been the thrust of the ISAAC approach. If the environ-
ment of populations is important in the occurrence of
asthma, rhinoconjunctivitis and eczema, as the evidence
suggests it is, analyses should be at the population envir-
onmental level. Thus ecological analyses are a most use-
ful way to examine the effect of the social, economic
and other aspects of the environment on health. As
Marmot has argued, analyses of individual risk factors
may be inappropriate if social environmental causes of
illness are sought [33]. The ecological approach has
been successful in suggesting hypotheses concerning
possible causes of international patterns of cancer in the
1950s and 1960s, which were investigated in depth in
further studies [34]. As some risk factors genuinely
operate at the population level, either directly causing
disease, or causing disease as effect modifiers or deter-
minants of exposure to individual risk factors, the pre-
diction of the health effects in an exposed population
can be of primary importance [35].
Naturally these data must be interpreted with care.
The potential problem with ecological studies is that the
relationship between factors at an ecological level may
not be the same as the relationship at an individual
level. It cannot be assumed that exposure-disease asso-
ciations in comparisons between populations necessarily
represent associations at the individual level - the ‘ecolo-
gical fallacy’ [36-38]. There may be several reasons for
this, including population-level confounding (popula-
tions differ for many variables that cannot be included
in the analysis), aggregation bias (grouping of disparate
types of individuals), and misclassification bias. On the
other hand, ecological studies are not susceptible to cer-
tain biases that can affect associations among indivi-
duals: for example, recall bias, when current disease
influences memory of exposure, and reverse causality, if
early symptoms lead to treatment (e.g. paracetamol) or
behaviour change (e.g. smoking cessation by parents)
that then appear to be adverse factors for the established
disease. The ecological approach may be the only way to
study the effect of whole population exposures, and the
problems of interpreting individual-level data are per-
haps less commonly appreciated.
Notwithstanding concerns about potential biases, the
large number of countries, centres and children partici-
pating provides an opportunity to identify themes for
further exploration relating to these three interrelated
conditions. These analyses were undertaken to make
ecological inferences about effects on population symp-
tom prevalence rates, rather than biological inferences
about effects on individual risks. In ISAAC Phase Three
there was individual exposure ascertainment with a
wider range of exposures providing the opportunity to
conduct parallel individual and centre (population) level
analyses, and further exploration of the ecological
approach.
Conclusion
ISAAC has explored environmental factors at a popula-
tion level which may relate to the prevalence of asthma,
rhinoconjunctivitis and eczema while recognising the
limitations of the ecological approach in causal inference
at the individual level. Some global associations which
could be explored by further research were positive
associations between the prevalence of symptoms of
asthma, rhinoconjunctivitis and eczema in populations
and GNP, trans fatty acids, paracetamol, and women
smoking and inverse associations between food of plant
origin, pollen, immunisations, tuberculosis notifications,
air pollution, and men smoking, and some showed
mixed effects (antibiotics and climatic factors). While
the global ecological approach has advantages, it may
miss factors of importance within regions, and involving
combinations of variables within or between regions.
ISAAC Phase Three has extended research in the areas
identified in this review using an environmental ques-
tionnaire which enables some of these hypotheses to be
explored further with individual level as well as ecologi-
cal analyses. Further studies could include randomised
controlled trials of putative risk factors such as paraceta-
mol exposure. Since these ecological studies took place,
globalization has introduced further large environmental
changes. Rapid environmental and lifestyle changes
within whole societies offers potential opportunities for
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demonstrating the importance of community-wide
determinants of ill-health, and provides a rationale for
monitoring time trends in asthma and allergic diseases
in diverse populations, as in Phase One centres that also
participated in ISAAC Phase Three.
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